April 07, 2021
Article
Patients with psoriasis who either remained on Humira or switched to a biosimilar showed similar retention rates and efficacy/safety data.
Video
A dermatologist discusses alternative and complementary options for the treatment of atopic dermatitis.
April 05, 2021
A dermatologist gives a broad overview of key considerations when determining a treatment course for pediatric patients.
April 04, 2021
The oral Janus kinase 1 inhibitor abrocitinib produced similar outcomes to dupilumab in a placebo-controlled comparison for atopic dermatitis.
April 03, 2021
The pandemic forced practices to consider more virtual screening and care. A dermatologist shares perspective on what's been working as telemedicine practice.
April 01, 2021
Mortality rates were similar in COVID-19 patients with and without chronic inflammatory diseases.
March 28, 2021
An expert offers his perspective on the investigative SLP receptor modulator for atopic dermatitis.
March 25, 2021
A dermatologist discusses some of her most common cosmetic practices and techniques.
March 17, 2021
A majority of patients with active psoriatic arthritis achieved and maintained skin clearance, joint symptom relief through year 2 of treatment.
Valerie Callender, MD, gives an overview of her practice and discusses the challenges during the COVID-19 pandemic.
